Topic: clinical trial ethics
Wednesday, November 6, 2019
Racial and ethnic minorities are under-represented in many clinical trials.
Pharma companies are learning to share. That is, when it comes to clinical research data, according to a new report.
Three people injected with an unauthorized herpes vaccine by a Southern Illinois University researcher have filed suit against his company.
It’s an A-plus for J&J and Sanofi. The second annual Good Pharma Scorecard assigned both drugmakers perfect scores of 100% for trial transparency.
Before heading offshore for a dubious herpes vaccine trial, a Southern Illinois University did such experiments on people in the U.S.
An American university and a group of wealthy libertarians, including Peter Thiel, are backing the offshore testing of an experimental herpes vaccine.
In this week's FiercePharmaAsia wrap-up, Astellas terminated an unfruitful vaccine deal, Takeda made a rare disease R&D pact, China's Sanpower has to deal with costly Provenge manufacturing, and more.
Not atypically, the FDA questioned Pfizer’s Chantix data up for discussion at a meeting Wednesday. But agency reviewers also raised an unusual flag: Pfizer's payments to doctors who participated in the trial.
Military hospitals in China are reportedly offering unapproved immunotherapy and stem cell treatments, promising miracle cures at steep fees.